期刊文献+

血清维生素D水平对HIV-1感染者的影响研究

Effect of serum vitamin D levels on HIV-1 infected individuals
在线阅读 下载PDF
导出
摘要 目的探讨血清维生素D水平对人类免疫缺陷病毒1型(HIV-1)感染者的影响。方法选取2021年1月至2023年7月长沙市第一医院接受HIV-1 DNA检测的经治HIV-1感染者411例,对其中92例维生素D缺乏的感染者进行补充试验,并按自愿原则分为研究组(42例)和对照组(50例)。分析不同特征HIV-1感染者维生素D缺乏情况,比较2组血清维生素D水平、T细胞亚群水平、HIV-1 DNA水平,并分析血清维生素D水平与T细胞亚群、HIV-1 DNA水平相关性。结果不同年龄段、抗反转录病毒治疗(ART)疗程、CD8^(+)T细胞计数水平及CD4/CD8比值HIV-1感染者血清维生素D缺乏率比较,差异有统计学意义(P<0.05)。≥40岁HIV-1感染者维生素D缺乏率明显低于<40岁感染者,差异有统计学意义(P<0.05)。血清维生素D水平与CD8^(+)T细胞计数水平呈负相关(r=—0.2510,P<0.05),与CD4/CD8比值呈正相关(r=0.1726,P<0.05),而与CD4^(+)T细胞计数水平无显著相关性(P>0.05)。血清维生素D水平与HIV-1 DNA水平呈负相关(r=—0.1022,P<0.05),与ART疗程呈正相关(r=0.1274,P<0.05)。2组基线血清维生素D、T细胞亚群水平比较,差异无统计学意义(P>0.05)。随访48周时,研究组血清维生素D、CD4^(+)T细胞计数、CD8^(+)T细胞计数水平高于基线时,差异有统计学意义(P<0.05),而对照组仅维生素D水平高于基线时(P=0.007),CD4^(+)T、CD8^(+)T细胞计数水平和CD4/CD8比值与基线时比较,差异无统计学意义(P>0.05)。随访48周时,研究组血清维生素D、CD8^(+)T细胞计数水平高于对照组,差异有统计学意义(P<0.05)。结论青年和ART早期的HIV-1感染者血清维生素D水平相对较低,补充维生素D3可改善其免疫功能,降低病毒储存水平。 Objective To investigate the influence of serum vitamin D levels on individuals infected with human immunodeficiency virus type 1(HIV-1).Methods A total of 411 treated HIV-1 infected patients undergoing HIV-1 DNA testing at the First Hospital of Changsha from January 2021 to July 2023 were included.Among them,92 infected individuals with vitamin D deficiency were subjected to supplementary test and divided into study group(42 cases)and control group(50 cases)according to voluntary basis.Analysis included assessment of vitamin D deficiency across different demographic and clinical characteristics of HIV-1 infected individuals,comparison of serum vitamin D levels,T-cell subset levels,and HIV-1 DNA levels between the two groups,and correlation analysis of serum vitamin D levels with T-cell subsets and HIV-1 DNA levels.Results Significant differences in serum vitamin D deficiency rates were observed among HIV-1 infected individuals across different age groups,antiretroviral therapy(ART)durations,CD8^(+)T-cell counts,and CD4/CD8 ratios(P<0.05).Individuals aged≥40 years exhibited significantly lower rates of vitamin D deficiency compared to those aged<40 years(P<0.05).Serum vitamin D levels were negatively correlated with CD8^(+)T-cell counts(r=-0.2510,P<0.05),positively correlated with CD4/CD8 ratios(r=0.1726,P<0.05),and showed no significant correlation with CD4^(+)T-cell counts(P>0.05).Serum vitamin D levels were negatively correlated with HIV-1 DNA levels(r=-0.1022,P<0.05)and positively correlated with ART duration(r=0.1274,P<0.05).There were no statistically significant differences in baseline serum vitamin D levels and T-cell subset levels between the study and control groups(P>0.05).At the 48-week follow-up,the study group showed significantly higher levels of serum vitamin D,CD4^(+)T-cell counts,and CD8^(+)T-cell counts compared to baseline(P<0.05),whereas the control group exhibited only higher serum vitamin D levels compared to baseline(P=0.007).Comparison of CD4^(+)T-cell counts,CD8^(+)T-cell counts,and CD4/CD8 ratios between the two groups at 48 weeks did not show statistically significant differences(P>0.05).At the 48-week follow-up,the study group had significantly higher serum vitamin D and CD8^(+)T-cell counts compared to the control group(P<0.05).Conclusion Younger individuals and those in early stages of ART with HIV-1 infection tend to have relatively lower serum vitamin D levels.Supplementation with vitamin D3 may improve immune function and reduce viral reservoir levels.
作者 彭勇权 曹旭健 汪雅婷 曾紫微 余维维 王敏 PENG Yongquan;CAO Xujian;WANG Yating;ZENG Ziwei;YU Weiwei;WANG Min(Graduate Collaborative Training Base,the First Hospital of Changsha and Hengyang Medical College,University of South China,Hengyang,Hunan 421001,China;The Institute of HIV/AIDS,the First Hospital of Changsha,Changsha,Hunan 410005,China)
出处 《现代医药卫生》 2024年第15期2521-2525,2532,共6页 Journal of Modern Medicine & Health
基金 湖南省创新型省份建设专项经费资助项目(2020SK21361)。
关键词 人类免疫缺陷病毒 维生素D 免疫功能 病毒储存库 Human immunodeficiency virus Vitamin D Immune function Viral repository
  • 相关文献

参考文献5

二级参考文献43

  • 1屠红,高海峰,马国豪,刘毅.肝癌中乙型肝炎病毒整合位点的研究[J].中华医学杂志,2006,86(18):1249-1252. 被引量:10
  • 2Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficieney vires infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med,1997, 337:725-733.
  • 3Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med , 1997,337:734-739.
  • 4Havlir DV, Koelsch KK, Strain MC, et al. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. Gilead 903 Study Team. J Infect Dis, 2005, 191:1164-1168.
  • 5Tiemey C, Lathey JL, Christopherson C, et al. Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. J Infect Dis,2003, 187:144-148.
  • 6McDermott JL, Girl AA, Martini I, et al. Level of human immunodeflciency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J Clin Microbiol, 1999,37:2361-2365.
  • 7Viard JP, Burgard M, Hubert JB, et al. Impact of 5 years of maximally successful highly active anfiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS, 2004,18:45-49.
  • 8Yerly S, Gunthard HF, Fagard C. Proviral HIV-DNA predicts viral rebound and viral set point after structured treatment interruptions. AIDS, 2004, 18:1951-1953.
  • 9Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T ceUs. Nat Med, 2003, 9:727-728.
  • 10Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication competent HIV despite prolonged suppression of plasma viremia. Science, 1997, 278:1291-1295.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部